1. Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia
- Author
-
Jung, Boris, Sebbane, Mustapha, Chanques, Gerald, Courouble, Patricia, Verzilli, Daniel, Perrigault, Pierre-Francois, Jean-Pierre, Helene, Eledjam, Jean-Jacques, and Jaber, Samir
- Subjects
Antibiotics -- Dosage and administration ,Bacterial pneumonia -- Risk factors ,Bacterial pneumonia -- Diagnosis ,Bacterial pneumonia -- Care and treatment ,Bacterial pneumonia -- Patient outcomes ,Pneumonia -- Risk factors ,Pneumonia -- Diagnosis ,Pneumonia -- Care and treatment ,Pneumonia -- Patient outcomes ,Trachea -- Intubation ,Trachea -- Health aspects ,Health care industry - Abstract
Byline: Boris Jung (1), Mustapha Sebbane (1), Gerald Chanques (1), Patricia Courouble (1), Daniel Verzilli (1), Pierre-Francois Perrigault (1), Helene Jean-Pierre (2), Jean-Jacques Eledjam (1), Samir Jaber (1) Keywords: Endotracheal aspiration; Broncho-alveolar lavage; Ventilator-associated pneumonia; Nosocomial pneumonia; Antibiotic therapy; Mechanical ventilation Abstract: Objectives Any delay in adequate antibiotic treatment compromises the outcome of ventilator-associated pneumonia (VAP). However, the diagnosis and optimal treatment of VAP remain a challenge for intensivists. We assessed the potential impact of using results of routine weekly endotracheal aspirate (EA) cultures to guide initial antibiotic treatment for VAP. Design and setting Retrospective analysis of prospectively collected data in a medical--surgical intensive care unit (ICU) of a university hospital. Patients and methods We studied 113 VAP episodes and evaluated the concordance between the latest EA and the broncho-alveolar lavage (BAL). We stratified patients into three groups: concordant EA--BAL (concordant group), discordant EA--BAL (discordant group) and EA not performed group. We then compared the adequacy of the antibiotic prescribed initially and outcomes between the three groups. Measurements and main results Ninety assessable EA--BAL samples were evaluated. When guided by EA, the initial antibiotic regimen was adequate in 85% of situations, a proportion significantly superior (P < 0.05) to that resulting from application of the ATS guidelines (73%). When clinicians did not have a pre-VAP EA to guide their treatment (EA not performed group), only 61% of treatments were adequate. No significant difference was observed between the three groups for length of mechanical ventilation, length of ICU stay, nonpulmonary nosocomial infections and mortality. Conclusion Once-a-week routine quantitative EA cultures may help to improve the adequacy of empiric antibiotic therapy for VAP. Author Affiliation: (1) Intensive Care Unit, Department of Critical Care and Anesthesiology, DAR B CHU de Montpellier, Hopital Saint Eloi, 80 Avenue Augustin Fliche, 34295, Montpellier Cedex 5, France (2) Bacteriology Department, CHU de Montpellier, Hopital Arnaud de Villeneuve, 191 Av Doyen Gaston Giraud, 34295, Montpellier Cedex 5, France Article History: Registration Date: 18/07/2008 Received Date: 14/07/2007 Accepted Date: 13/07/2008 Online Date: 19/08/2008 Article note: This article is discussed in the editorial available at: doi: 10.1007/s00134-008-1249-7. Presented in part at the 2006 Annual Meeting of European Society of Intensive Care Medicine (Barcelona, Spain, 24--27 September 2006). All authors declare the absence of any involvement in any organization with a direct financial interest in the subject of the manuscript.
- Published
- 2009